Investor Stock List
Ranked #1,636 of 8,699 institutional investors

Nextech Invest Ltd.

Zurich, V8

$1.78B
US stock portfolio at live prices · today −$7.9M (−0.44%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$2.23B
Change from Q2 2026
+$125.0M (+5.93%)
Positions
18 · 4 new, 1 sold out
Filed
Nov 16, 2026

Holdings

Q3 2026 13F, live prices
RVMD 68.1%PBLS 7.24%RLAY 6.06%TYRA 3.82%ORIC 3.10%
StockSharesValue, live% of portfoliovs Q2 2026
RVMD Revolution Medicines, Inc.7,601,087$1.21B68.1%Unchanged
PBLS Parabilis Medicines, Inc.4,663,176$129M7.24%Unchanged
RLAY Relay Therapeutics, Inc.6,776,506$108M6.06%Unchanged
TYRA Tyra Biosciences, Inc.3,447,482$68.0M3.82%Reduced −3%
ORIC ORIC Pharmaceuticals, Inc.7,162,637$55.2M3.10%Unchanged
SLN Silence Therapeutics plc1,693,140$33.5M1.89%Added +78%
KYMR Kymera Therapeutics, Inc.278,896$33.3M1.87%Unchanged
ZYME Zymeworks Inc.1,113,946$29.9M1.68%Unchanged
ATTO Attovia Therapeutics, Inc.1,835,139$28.6M1.61%New
ETRA Electra Therapeutics, Inc.2,636,225$23.6M1.32%New
ALMS Alumis Inc.4,550,998$19.7M1.11%Added +29%
CTMX CytomX Therapeutics, Inc.4,449,932$9.1M0.51%Unchanged
BRVE Braveheart Bio, Inc.416,700$8.0M0.45%New
GLUE Monte Rosa Therapeutics, Inc.761,153$6.8M0.38%Unchanged
AVTX Avalo Therapeutics, Inc.766,000$5.2M0.29%New
CRVS Corvus Pharmaceuticals, Inc.450,000$4.5M0.25%Unchanged
ENGN enGene Therapeutics Inc.2,324,943$4.1M0.23%Unchanged
CNTX Context Therapeutics Inc.7,419,355$1.3M<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ARVN Arvinas, Inc.1,122,713$7.6M